Evaluation of the Keeogo exoskeleton for assisting ambulatory activities in people with multiple sclerosis: an open-label, randomized, cross-over trial.

For group A, 6 MW test change scores for hW were greater than change scores for hWO, but failed to reach significance ( p = .028).

also in 4,113 other papers

Both groups A and B increased their total daily step count when using Keeogo in the home compared to the period when not using Keeogo at home, but it failed to reach statistical significance ( p = .046).

also in 6,035 other papers